A not too long ago listed small-cap pharmaceutical firm’s shares jumped as much as 17% to an intraday excessive of Rs 584 after reporting sturdy Q3 numbers. The corporate noticed a formidable 130% bounce in its internet earnings in the course of the quarter whereas its revenues are up by 31% YoY.
Share Value Motion
The shares of Senores Prescribed drugs Ltd, closed at Rs 549 per share, which was round 10% above its earlier shut of Rs 498.50 apiece and with a market cap of Rs 2,512.91 Crores. The shares generated a 6.5% return over the previous 5 days. The 52-week Excessive of the shares was Rs 609 per share, with a 52-week Low of Rs 440 per share.
Q3FY25 Outcomes
Senores Prescribed drugs Ltd reported a rise of 131% in Internet Earnings 12 months-on-12 months, from Rs 7.11 Crores in Q3FY24 to Rs 16.43 Crores in Q3FY25. Equally, their income reported a rise of 31%, from Rs 78.70 Crores to Rs 103.02 Crores over the identical interval.
Their EBITDA noticed a major progress of round 92%, from Rs 15.2 Crores to Rs 29.1 Crores over the identical interval. The corporate’s revenue margin elevated from 9% in Q3FY24 to 16.1% in Q3FY25.
Income Breakup
In Q3FY24, the corporate generated nearly all of its income from developed markets, contributing 87% of whole income. Income from rising markets accounted for 8.5%, whereas different markets contributed 4.5%. Nonetheless, in Q3FY25, the income combine shifted, with developed markets contributing 68.1%, rising markets rising to 25.3%, and different markets accounting for six.6%.
Administration Commentary
In Q3 FY25, the administration highlighted the launch of 1 new product and the receipt of ANDA approval for 5 merchandise within the developed markets enterprise, bringing the whole variety of ANDA approvals to 24. Moreover, their registered product portfolio within the Rising Markets enterprise grew to 267 merchandise.
Additionally learn….
Operational Highlights
The corporate at present holds a various portfolio in each developed and rising markets. Within the developed markets, it has 22 owned industrial merchandise, 24 authorised ANDAs, and 51 pipeline merchandise, together with 28 within the CGT (Cell and Gene Remedy) alternative class.
Moreover, it has 21 industrial merchandise in CDMO/CMO (Contract Growth and Manufacturing Group/Contract Manufacturing Group) and 69 pipeline merchandise on this space. In rising markets, the corporate boasts 237 authorised merchandise, with 537 merchandise below registration, and maintains a presence in over 40 nations.
IPO Particulars
The worth band for the IPO was set between ₹372 and ₹391 per share. The shares had been listed on BSE and NSE on December 30, 2024, with a 53% premium at Rs 600 on NSE. The IPO raised ₹582.11 crores by means of a book-built course of, comprising a contemporary situation of 1.28 crore shares and a suggestion on the market of 0.21 crore shares.
About Senores Prescribed drugs Ltd
Senores Prescribed drugs Restricted is a world, research-driven pharmaceutical firm centered on creating and manufacturing a broad vary of pharmaceutical merchandise. The corporate primarily serves developed markets just like the US, Canada, and different rising markets throughout varied therapeutic areas and dosage varieties. The corporate has manufactured over 270 Business merchandise serving over 300 prospects throughout 49 nations.
Written By Adhvaitha Nayani
Disclaimer
The views and funding suggestions expressed by funding consultants/broking homes/ranking businesses on tradebrains.in are their very own, and never that of the web site or its administration. Investing in equities poses a threat of monetary losses. Traders should subsequently train due warning whereas investing or buying and selling in shares. Dailyraven Applied sciences or the creator will not be chargeable for any losses triggered because of the choice primarily based on this text. Please seek the advice of your funding advisor earlier than investing.
Begin Your Inventory Market Journey Immediately!
Wish to study Inventory Market buying and selling and Investing? Make certain to take a look at unique Inventory Market programs by FinGrad, the training initiative by Commerce Brains. You’ll be able to enroll in FREE programs and webinars out there on FinGrad at this time and get forward in your buying and selling profession. Be part of now!!
